It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
The company is moving towards complex and more differentiated products
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The start-up has announced the scheme to mark World Diabetes Day
The centre has an initial capacity of 500 FTEs
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Subscribe To Our Newsletter & Stay Updated
